Prati
Preston D. Crowell
Preston D. Crowell
Scientist II, Stemson Therapeutics
Potvrđena adresa e-pošte na ucla.edu
Naslov
Citirano
Citirano
Godina
Expansion of luminal progenitor cells in the aging mouse and human prostate
PD Crowell, JJ Fox, T Hashimoto, JA Diaz, HI Navarro, GH Henry, ...
Cell reports 28 (6), 1499-1510. e6, 2019
712019
CD38 is methylated in prostate cancer and regulates extracellular NAD+
J Mottahedeh, MC Haffner, TR Grogan, T Hashimoto, PD Crowell, ...
Cancer & metabolism 6, 1-17, 2018
392018
Aging of the progenitor cells that initiate prostate cancer
J Freeland, PD Crowell, JM Giafaglione, PC Boutros, AS Goldstein
Cancer letters 515, 28-35, 2021
362021
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
JM Giafaglione, PD Crowell, AML Delcourt, T Hashimoto, SM Ha, ...
Nature cell biology 25 (12), 1821-1832, 2023
252023
Functional evidence that progenitor cells near sites of inflammation are precursors for aggressive prostate cancer
PD Crowell, AS Goldstein
Molecular & Cellular Oncology 4 (2), e1279723, 2017
192017
Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming
PD Crowell, JM Giafaglione, T Hashimoto, AS Goldstein
American Journal of Clinical and Experimental Urology 8 (4), 140, 2020
112020
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
PD Crowell, JM Giafaglione, AE Jones, NM Nunley, T Hashimoto, ...
Cell Reports 42 (10), 2023
92023
Evaluating the differentiation capacity of mouse prostate epithelial cells using organoid culture
PD Crowell, JM Giafaglione, T Hashimoto, JA Diaz, AS Goldstein
Journal of visualized experiments: JoVE, 10.3791/60223, 2019
82019
Defining regulation of prostate cancer initiation, progression, and resistance to androgen receptor blockade
PD Crowell
University of California, Los Angeles, 2022
2022
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–9